196 related articles for article (PubMed ID: 33893085)
1.
Huang SP; Chen LC; Chen YT; Lee CH; Huang CY; Yu CC; Lin VC; Lu TL; Bao BY
Cancer Genomics Proteomics; 2021; 18(3):325-334. PubMed ID: 33893085
[TBL] [Abstract][Full Text] [Related]
2. The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.
Bielli P; Panzeri V; Lattanzio R; Mutascio S; Pieraccioli M; Volpe E; Pagliarulo V; Piantelli M; Giannantoni A; Di Stasi SM; Sette C
Clin Cancer Res; 2018 Nov; 24(21):5422-5432. PubMed ID: 30012566
[No Abstract] [Full Text] [Related]
3. Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.
Takahashi H; Nishimura J; Kagawa Y; Kano Y; Takahashi Y; Wu X; Hiraki M; Hamabe A; Konno M; Haraguchi N; Takemasa I; Mizushima T; Ishii M; Mimori K; Ishii H; Doki Y; Mori M; Yamamoto H
Mol Cancer Ther; 2015 Jul; 14(7):1705-16. PubMed ID: 25904505
[TBL] [Abstract][Full Text] [Related]
4. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
[TBL] [Abstract][Full Text] [Related]
5. PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC.
Gong H; Jiang A; Jiang R; Wang Y; Zhang D; Wu Z; Xiao J
Oxid Med Cell Longev; 2022; 2022():5687238. PubMed ID: 35651729
[TBL] [Abstract][Full Text] [Related]
6. PTBP1 is a Novel Poor Prognostic Factor for Glioma.
Liu P; He GC; Tan YZ; Liu GX; Liu AM; Zhu XP; Zhou Y; Hu WM
Biomed Res Int; 2022; 2022():7590997. PubMed ID: 35299889
[TBL] [Abstract][Full Text] [Related]
7. PTBP1 enhances exon11a skipping in Mena pre-mRNA to promote migration and invasion in lung carcinoma cells.
Li S; Shen L; Huang L; Lei S; Cai X; Breitzig M; Zhang B; Yang A; Ji W; Huang M; Zheng Q; Sun H; Wang F
Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):858-869. PubMed ID: 31075540
[TBL] [Abstract][Full Text] [Related]
8. A pan-cancer analysis of the oncogenic role of polypyrimidine tract binding protein 1 (PTBP1) in human tumors.
Huang Q; Gu S; Fang J; Li X; Lin L
Medicine (Baltimore); 2022 Dec; 101(52):e32428. PubMed ID: 36595978
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response.
Huan L; Guo T; Wu Y; Xu L; Huang S; Xu Y; Liang L; He X
Mol Cancer; 2020 Jan; 19(1):11. PubMed ID: 31964396
[TBL] [Abstract][Full Text] [Related]
10. Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy.
Geng JH; Lin VC; Yu CC; Huang CY; Yin HL; Chang TY; Lu TL; Huang SP; Bao BY
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898031
[TBL] [Abstract][Full Text] [Related]
11. Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.
Wang X; Harshman LC; Xie W; Nakabayashi M; Qu F; Pomerantz MM; Lee GS; Kantoff PW
J Clin Oncol; 2016 Feb; 34(4):352-9. PubMed ID: 26668348
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy.
Huang CN; Huang SP; Pao JB; Chang TY; Lan YH; Lu TL; Lee HZ; Juang SH; Wu PP; Pu YS; Hsieh CJ; Bao BY
Ann Oncol; 2012 Mar; 23(3):707-713. PubMed ID: 21652578
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapy.
Zhang QX; Pan YM; Xiao HL; An N; Deng SS; Du X
Neoplasma; 2022 Sep; 69(5):1198-1208. PubMed ID: 36131606
[TBL] [Abstract][Full Text] [Related]
14. A miR-194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma.
Kang H; Heo S; Shin JJ; Ji E; Tak H; Ahn S; Lee KJ; Lee EK; Kim W
J Pathol; 2019 Nov; 249(3):395-408. PubMed ID: 31301177
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy.
Huang CN; Huang SP; Pao JB; Hour TC; Chang TY; Lan YH; Lu TL; Lee HZ; Juang SH; Wu PP; Huang CY; Hsieh CJ; Bao BY
J Intern Med; 2012 May; 271(5):499-509. PubMed ID: 21880074
[TBL] [Abstract][Full Text] [Related]
16. Functional interactions between polypyrimidine tract binding protein and PRI peptide ligand containing proteins.
Coelho MB; Ascher DB; Gooding C; Lang E; Maude H; Turner D; Llorian M; Pires DE; Attig J; Smith CW
Biochem Soc Trans; 2016 Aug; 44(4):1058-65. PubMed ID: 27528752
[TBL] [Abstract][Full Text] [Related]
17. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
[TBL] [Abstract][Full Text] [Related]
18. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1.
Cheng C; Ding Q; Zhang Z; Wang S; Zhong B; Huang X; Shao Z
J Cell Mol Med; 2020 May; 24(9):5274-5289. PubMed ID: 32207235
[TBL] [Abstract][Full Text] [Related]
19. Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
Jo YK; Roh SA; Lee H; Park NY; Choi ES; Oh JH; Park SJ; Shin JH; Suh YA; Lee EK; Cho DH; Kim JC
Cancer Lett; 2017 Jan; 385():21-27. PubMed ID: 27836735
[TBL] [Abstract][Full Text] [Related]
20. PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis.
Rawcliffe DFR; Österman L; Nordin A; Holmberg M
Mol Genet Genomic Med; 2018 Nov; 6(6):887-897. PubMed ID: 30209894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]